Research Update

Sublocade vs SL Buprenorphine after Release from Jail

Topics: Buprenorphine | Incarceration | long-acting buprenorphine | OUD

REVIEW OF: Lee JD et al, JAMA Netw Open 2021;4(9):e2123032 STUDY TYPE: Randomized comparative effectiveness trial When people with opioid use disorder (OUD) are released from incarceration, they have a high risk of overdose—especially if they are not prescribed any medication for OUD. We know that methadone, sublingual buprenorphine/naloxone (SL

Read More